Photodynamic therapy of squamous cell carcinoma. An evaluation of a new photosensitizing agent, benzoporphyrin derivative and new photoimmunoconjugate
- 31 December 1993
- journal article
- research article
- Published by Elsevier in Surgical Oncology
- Vol. 2 (3) , 187-196
- https://doi.org/10.1016/0960-7404(93)90006-k
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The Chemistry, Photophysics and Photosensitizing Properties of PhthalocyaninesPublished by Wiley ,2007
- Detection of squamous cell cancer and pre-cancerous lesions by imaging of tissue autofluorescence in the hamster cheek pouch modelSurgical Oncology, 1992
- Photodynamic Killing of Human Squamous Cell Carcinoma Cells Using a Monoclonal Antibody-Photosensitizer ConjugateJNCI Journal of the National Cancer Institute, 1991
- Radiolabeled Antibody Imaging in the Management of Colorectal Cancer Results of a Multicenter Clinical StudyAnnals of Surgery, 1991
- Use of photodynamic therapy in the palliation of massive advanced rectal cancerDiseases of the Colon & Rectum, 1991
- Hematoporphyrin photodynamic therapy: Is there truly a future in head and neck oncology? Reflections on a 5‐year experienceThe Laryngoscope, 1991
- Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing miceJournal of Photochemistry and Photobiology B: Biology, 1990
- STRATEGIES FOR SELECTIVE CANCER PHOTOCHEMOTHERAPY: ANTIBODY‐TARGETED and SELECTIVE CARCINOMA CELL PHOTOLYSIS*Photochemistry and Photobiology, 1987
- PHOTOSENSITIZERS: THERAPY AND DETECTION OF MALIGNANT TUMORSPhotochemistry and Photobiology, 1987
- Human squamous cell lung cancers express increased epidermal growth factor receptors.Journal of Clinical Investigation, 1984